- The document discusses acute respiratory distress syndrome (ARDS), including its definition, classifications, pathophysiology, clinical presentation, investigations, and management principles.
- ARDS is defined as acute diffuse lung inflammation causing hypoxemia. It is classified as mild, moderate or severe based on levels of hypoxemia. Management focuses on treating the underlying cause, supportive care including mechanical ventilation with low tidal volumes, and permissive hypercapnia to prevent further lung injury.
1) The document discusses the use of noninvasive ventilation (NIV) to facilitate weaning patients from mechanical ventilation. Several randomized controlled trials have found NIV can successfully facilitate weaning, particularly in COPD patients.
2) NIV is recommended for COPD patients who have failed an initial spontaneous breathing trial but have otherwise recovered from their acute illness. Close monitoring is required when using NIV for weaning.
3) The trials indicate NIV may shorten ventilation time compared to remaining intubated, but the evidence for NIV is strongest for facilitating weaning and not as a rescue therapy for post-extubation respiratory failure.
HFNC therapy provides high flow oxygen through a nasal cannula. It has several benefits over traditional oxygen delivery methods, including more accurate oxygen delivery, washout of dead space, and generation of positive end-expiratory pressure. HFNC is a well-tolerated therapy that can be used for hypoxemic respiratory failure, pre-intubation, and post-extubation. While promising, further research is still needed to establish clear guidelines for its use.
An elderly woman with multiple comorbidities suffered from COVID 19 moderate disease - was managed conservatively
Case presentation with current treatment modalities
Non Invasive Ventilation (NIV) involves delivering mechanical ventilation without the use of an endotracheal tube or surgical airway, instead using a tight-fitting face or nasal mask. NIV has been used since the 1940s but became more widely used starting in the 1980s for conditions like sleep apnea. It is now commonly used to treat acute respiratory failure from COPD exacerbations and cardiogenic pulmonary edema. NIV can be delivered via CPAP or BiPAP and involves optimizing settings like IPAP, EPAP, respiratory rate and oxygen flow to improve ventilation and oxygenation without the need for intubation. Proper patient selection, interface choice, and monitoring are important for successful NIV treatment.
Call for help early if refractory hypoxemia persists despite troubleshooting steps. Consider prone positioning, nitric oxide, paralysis, and ECMO to improve oxygenation in severe cases.
This document discusses the use of noninvasive ventilation (NIV) for patients with COVID-19-associated acute hypoxemic respiratory failure (AHRF). It finds that the majority of COVID-19 patients treated with continuous positive airway pressure (CPAP) recovered from moderate-to-severe AHRF. For select patients, NIV may prevent intubation and invasive ventilation. However, patient selection is important and NIV may delay intubation in some cases. Close monitoring is needed to identify patients who require intubation.
1. The document provides guidelines for managing acute exacerbations of chronic obstructive pulmonary disease (COPD) including diagnostic criteria, treatment recommendations, and referral criteria.
2. Key recommendations include using oxygen therapy, bronchodilators, corticosteroids, and antibiotics to treat exacerbations. Non-invasive ventilation may also be used if certain clinical criteria are met.
3. The guidelines distinguish standards of care for secondary/non-metro hospitals versus specialty facilities in metro areas, noting higher-end tests and treatments available in metro locations like CT scans, echocardiograms, and non-invasive ventilation. Close monitoring of patients is emphasized.
This document discusses several conditions that can mimic or be misdiagnosed as bronchial asthma, including vocal cord dysfunction, cardiac asthma, gastroesophageal reflux disease, postnasal drip syndrome, and reactive airways dysfunction syndrome. It provides details on the clinical presentation and diagnostic criteria for each condition. The key points are that these "asthma mimics" are commonly treated as asthma, leading to overuse of medications and poor outcomes for patients, and a high index of suspicion for alternative diagnoses should be considered for patients who do not respond to typical asthma treatment. Diagnosis of the mimics often requires specialized testing like laryngoscopy.
1) The document discusses the use of noninvasive ventilation (NIV) to facilitate weaning patients from mechanical ventilation. Several randomized controlled trials have found NIV can successfully facilitate weaning, particularly in COPD patients.
2) NIV is recommended for COPD patients who have failed an initial spontaneous breathing trial but have otherwise recovered from their acute illness. Close monitoring is required when using NIV for weaning.
3) The trials indicate NIV may shorten ventilation time compared to remaining intubated, but the evidence for NIV is strongest for facilitating weaning and not as a rescue therapy for post-extubation respiratory failure.
HFNC therapy provides high flow oxygen through a nasal cannula. It has several benefits over traditional oxygen delivery methods, including more accurate oxygen delivery, washout of dead space, and generation of positive end-expiratory pressure. HFNC is a well-tolerated therapy that can be used for hypoxemic respiratory failure, pre-intubation, and post-extubation. While promising, further research is still needed to establish clear guidelines for its use.
An elderly woman with multiple comorbidities suffered from COVID 19 moderate disease - was managed conservatively
Case presentation with current treatment modalities
Non Invasive Ventilation (NIV) involves delivering mechanical ventilation without the use of an endotracheal tube or surgical airway, instead using a tight-fitting face or nasal mask. NIV has been used since the 1940s but became more widely used starting in the 1980s for conditions like sleep apnea. It is now commonly used to treat acute respiratory failure from COPD exacerbations and cardiogenic pulmonary edema. NIV can be delivered via CPAP or BiPAP and involves optimizing settings like IPAP, EPAP, respiratory rate and oxygen flow to improve ventilation and oxygenation without the need for intubation. Proper patient selection, interface choice, and monitoring are important for successful NIV treatment.
Call for help early if refractory hypoxemia persists despite troubleshooting steps. Consider prone positioning, nitric oxide, paralysis, and ECMO to improve oxygenation in severe cases.
This document discusses the use of noninvasive ventilation (NIV) for patients with COVID-19-associated acute hypoxemic respiratory failure (AHRF). It finds that the majority of COVID-19 patients treated with continuous positive airway pressure (CPAP) recovered from moderate-to-severe AHRF. For select patients, NIV may prevent intubation and invasive ventilation. However, patient selection is important and NIV may delay intubation in some cases. Close monitoring is needed to identify patients who require intubation.
1. The document provides guidelines for managing acute exacerbations of chronic obstructive pulmonary disease (COPD) including diagnostic criteria, treatment recommendations, and referral criteria.
2. Key recommendations include using oxygen therapy, bronchodilators, corticosteroids, and antibiotics to treat exacerbations. Non-invasive ventilation may also be used if certain clinical criteria are met.
3. The guidelines distinguish standards of care for secondary/non-metro hospitals versus specialty facilities in metro areas, noting higher-end tests and treatments available in metro locations like CT scans, echocardiograms, and non-invasive ventilation. Close monitoring of patients is emphasized.
This document discusses several conditions that can mimic or be misdiagnosed as bronchial asthma, including vocal cord dysfunction, cardiac asthma, gastroesophageal reflux disease, postnasal drip syndrome, and reactive airways dysfunction syndrome. It provides details on the clinical presentation and diagnostic criteria for each condition. The key points are that these "asthma mimics" are commonly treated as asthma, leading to overuse of medications and poor outcomes for patients, and a high index of suspicion for alternative diagnoses should be considered for patients who do not respond to typical asthma treatment. Diagnosis of the mimics often requires specialized testing like laryngoscopy.
NON PHARMACOLOGICAL AND SURGICAL MANAGEMENT OF COPD _ 14SoM
Surgical interventions such as bullectomy, lung volume reduction surgery (LVRS), and lung transplantation can benefit select COPD patients. Bullectomy and LVRS provide short-term improvements in lung function, exercise capacity, and dyspnea, but benefits often deteriorate over time. LVRS offers the most benefit for patients with upper lobe-dominant disease. Lung transplantation carries risks of rejection and infection but can significantly extend life for COPD patients. Careful patient selection is important for achieving successful outcomes with these procedures.
The document provides guidelines for the management of COVID-19 patients at AMCH Dibrugarh. It outlines protocols for treating mild, moderate, and severe cases based on symptoms and oxygen needs. For moderate cases, it recommends empirical treatment, oxygen therapy, antibiotics, thromboprophylaxis, hydration, corticosteroids, awake proning, and clinical follow-up. For severe cases requiring ICU care, it adds supportive treatments and discusses mechanical ventilation, renal replacement therapy, and management of conditions like septic shock. The document provides detailed protocols for oxygen delivery methods, ventilation techniques, and monitoring critically ill patients.
Presentation of Dr. Dean Hess at 10th Pulmonary Medicine Update Course, Cairo, Egypt. Pulmonary Medicine Update Course is organized by Scribe : www.scribeofegypt.com
Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease characterized by persistent respiratory symptoms and airflow limitation. It includes chronic bronchitis and emphysema. The main risk factor is cigarette smoking. Symptoms include dyspnea, cough, and sputum production. Diagnosis is confirmed by spirometry showing airflow limitation. Management involves smoking cessation, bronchodilators, pulmonary rehabilitation, oxygen therapy, and treating exacerbations with corticosteroids and antibiotics.
COPD is a progressive lung disease characterized by airflow obstruction caused by chronic bronchitis or emphysema. It is the fourth leading cause of death in the US. Symptoms include cough, sputum production, and shortness of breath. Management involves smoking cessation, bronchodilators, corticosteroids, oxygen therapy, and lifestyle changes. Nurses play a key role in assessing patients, educating on self-management, and providing interventions to improve breathing and nutrition.
This document provides information on bronchial asthma, including:
- Asthma is a chronic inflammatory airway disease characterized by wheezing, breathlessness, and coughing.
- It affects over 350 million people globally and causes nearly 400,000 deaths per year, most in developing countries.
- Long-term treatment involves inhaled corticosteroids to reduce inflammation. Other treatments include oral corticosteroids, leukotriene modifiers, and long-acting beta-2 agonists.
- Triggers include infections, allergens, exercise, air pollution, weather changes, drugs, stress, and smoking. Proper management is needed to prevent complications and control symptoms.
This document discusses non-invasive positive pressure ventilation (NIPPV). It defines NIPPV as ventilation without an invasive airway and notes its increasing use for acute respiratory failure. The document covers the history of NIPPV, indications, goals, advantages, patient selection criteria, initiation procedures, modes (including CPAP, BiPAP, volume vs pressure), and settings. NIPPV can effectively treat various conditions like COPD, heart failure, and respiratory infections while avoiding intubation. Careful patient selection and monitoring are important for successful NIPPV.
This document discusses various chest and lower respiratory tract disorders including atelectasis, respiratory infections like pneumonia, diagnostic tests, medical treatments, and nursing care. Specific topics covered include prevention and treatment of atelectasis, types of pneumonia, nursing assessments and interventions for patients with pneumonia, diagnostic testing for pneumonia, medical management of pneumonia, respiratory infections like bronchitis, diagnostic testing and medical treatment of pneumonia, nursing care for patients with lung cancer, and chest trauma conditions.
This document provides guidance on ventilatory management of COVID-19 patients. It discusses preparing ICU units, criteria for ICU admission, general measures including oxygen supplementation and ventilation strategies. It covers the use of HFNO, NIV, intubation and airway management precautions. Ventilation strategies for ARDS like lung protective ventilation with lower tidal volumes are recommended. Other strategies like prone positioning, higher PEEP and recruitment maneuvers are discussed. ECMO is considered for refractory hypoxemia. Weaning, extubation and complications are also addressed.
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHEDevawrat Buche
COPD is a common preventable disease characterized by persistent airflow limitation associated with chronic inflammation in the airways and lungs due to noxious particles. The severity of COPD is assessed using symptoms, spirometry results, exacerbation risk, and comorbidities. Treatment involves smoking cessation, pharmacotherapy including bronchodilators and inhaled corticosteroids, rehabilitation, vaccination, and management of exacerbations with oxygen therapy, bronchodilators, corticosteroids, and antibiotics.
An overview of adult respiratory distress syndrome with a focus on the updates in ventilatory management of this important syndrome in the intensive care
These slides represent how to manage patients on a mechanical ventilator? Easy understanding of using ventilators. indication of mechanical ventilator use. How to wean a patient from a mechanical ventilator? How to fine-tune the ventilator settings?
This document summarizes a study comparing non-invasive positive pressure ventilation (NIPPV) to high flow oxygen therapy in immunocompromised patients with acute respiratory failure. The study found that early use of NIPPV as compared to oxygen therapy alone did not reduce 28-day mortality or intubation rates. There were also no differences in ICU or hospital length of stay. While NIPPV did not provide benefits, the lower than expected mortality with oxygen therapy alone limited the study's ability to detect differences between the groups.
This document discusses a case of a 45-year-old male presenting with toe pain secondary to gout who had an IV placed with subsequent air embolism due to failure to flush the IV tubing. It prompts for the diagnosis and treatment. Air embolism would be the diagnosis, and treatment would involve placing the patient in left lateral decubitus position and administering 100% oxygen via non-rebreather mask to reduce the size of the air bubbles and support oxygenation. The document goes on to discuss various topics relating to hyperbaric oxygen therapy including its physics, physiology, indications, disadvantages, evidence for use in emergency medicine, and reimbursement issues.
The document discusses chronic obstructive pulmonary disease (COPD) and its diagnosis and assessment. It provides guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for diagnosing and assessing COPD severity. Key points include that COPD is diagnosed based on symptoms and post-bronchodilator spirometry. Severity is assessed based on airflow limitation using spirometry grades (GOLD 1-4), exacerbation history, and symptoms using scales like mMRC and CAT. A combined assessment places patients into one of four categories (A-D) to guide management.
This document presents 6 case studies of patients presenting with dyspnoea or shortness of breath. Case 1 describes a 72-year-old woman admitted to the hospital with fever and progressive shortness of breath with a history of rheumatoid arthritis. Case 2 involves a 45-year-old heavy smoker with increasing dyspnea, cough, and finger clubbing. Case 3 is about a 76-year-old man with exertional dyspnea and multiple conditions including myasthenia gravis. Case 4 presents a 48-year-old male with fever, cough, weight loss, and right-sided chest pain and shortness of breath. Case 5 describes a 66-year-old woman with increasing shortness
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with high costs, morbidity, and mortality. They result in enormous healthcare expenditures and lost productivity. AECOPD episodes are also linked to accelerated long-term loss of lung function in continuous smokers. While symptoms may recover within a week, full recovery of health-related quality of life can take months. Noninvasive mechanical ventilation should be tried for patients with respiratory acidosis or increased work of breathing from AECOPD as it reduces intubation rates and improves health outcomes. Preventing and properly managing AECOPD is important for reducing its impacts.
Noninvasive ventilation may provide benefits as a weaning strategy compared to invasive weaning from mechanical ventilation. A systematic review and meta-analysis of randomized controlled trials found that noninvasive weaning significantly reduced mortality, rates of weaning failure and ventilator-associated pneumonia. It also decreased length of stay in the ICU and hospital as well as total duration of mechanical ventilation compared to invasive weaning. Subgroup analysis showed greater reduction in mortality for patients with COPD using noninvasive weaning.
1) ARDS is a common and serious condition in the ICU characterized by diffuse lung inflammation and damage to the lungs' ability to oxygenate blood. It can develop due to direct or indirect injury to the lungs from a variety of causes like pneumonia, sepsis, trauma, etc.
2) Mechanical ventilation can further damage injured lungs if not performed carefully. A lung protective strategy using low tidal volumes has been shown to significantly reduce mortality in ARDS patients.
3) Treatment involves identifying and treating the underlying cause, conservative fluid management, nutritional support, and lung protective ventilation with low tidal volumes and adequate PEEP to prevent lung collapse without overdistension.
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by rapid onset of severe breathing difficulties, low oxygen levels in the blood, and diffuse lung inflammation and fluid buildup leading to respiratory failure. It has two phases - an initial exudative phase where lung inflammation causes fluid buildup in the lungs, and a later proliferative phase where the lungs try to heal but can develop pulmonary fibrosis. Treatment focuses on supportive care, minimizing additional lung injury from mechanical ventilation, maintaining low fluid levels to prevent further pulmonary edema, and managing the underlying cause of the ARDS when possible. The mainstay of ventilation treatment is using low tidal volumes and adequate positive end-expiratory pressure to safely recruit and maintain open lung volumes without over
Dr. Nannika Pradhan presented on pulmonary hypertension (PH). The key points discussed include:
1. PH is defined as a mean pulmonary arterial pressure ≥25 mmHg at rest as assessed by right heart catheterization.
2. PH is classified clinically into 5 groups based on etiology.
3. Clinical features include dyspnea, chest pain, syncope, signs of right heart failure. Diagnosis involves echocardiogram, CT scan, ventilation-perfusion scan and right heart catheterization.
4. Treatment depends on disease severity and involves diuretics, oxygen supplementation, calcium channel blockers, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostano
This document provides information on Acute Respiratory Distress Syndrome (ARDS), including its history, definitions, pathophysiology, management, and related concepts like ventilator-induced lung injury. Some key points:
- ARDS was first described in 1967 and its definition has evolved, with the most widely used being the Berlin Definition from 2012.
- It is characterized by diffuse pulmonary edema and inflammation due to direct lung injury or indirect causes like sepsis.
- Management focuses on treating the underlying cause, protective lung ventilation with low tidal volumes, permissive hypercapnia, prone positioning, and recruitment maneuvers.
- Adjunctive techniques aim to prevent ventilator-induced lung injury from
NON PHARMACOLOGICAL AND SURGICAL MANAGEMENT OF COPD _ 14SoM
Surgical interventions such as bullectomy, lung volume reduction surgery (LVRS), and lung transplantation can benefit select COPD patients. Bullectomy and LVRS provide short-term improvements in lung function, exercise capacity, and dyspnea, but benefits often deteriorate over time. LVRS offers the most benefit for patients with upper lobe-dominant disease. Lung transplantation carries risks of rejection and infection but can significantly extend life for COPD patients. Careful patient selection is important for achieving successful outcomes with these procedures.
The document provides guidelines for the management of COVID-19 patients at AMCH Dibrugarh. It outlines protocols for treating mild, moderate, and severe cases based on symptoms and oxygen needs. For moderate cases, it recommends empirical treatment, oxygen therapy, antibiotics, thromboprophylaxis, hydration, corticosteroids, awake proning, and clinical follow-up. For severe cases requiring ICU care, it adds supportive treatments and discusses mechanical ventilation, renal replacement therapy, and management of conditions like septic shock. The document provides detailed protocols for oxygen delivery methods, ventilation techniques, and monitoring critically ill patients.
Presentation of Dr. Dean Hess at 10th Pulmonary Medicine Update Course, Cairo, Egypt. Pulmonary Medicine Update Course is organized by Scribe : www.scribeofegypt.com
Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease characterized by persistent respiratory symptoms and airflow limitation. It includes chronic bronchitis and emphysema. The main risk factor is cigarette smoking. Symptoms include dyspnea, cough, and sputum production. Diagnosis is confirmed by spirometry showing airflow limitation. Management involves smoking cessation, bronchodilators, pulmonary rehabilitation, oxygen therapy, and treating exacerbations with corticosteroids and antibiotics.
COPD is a progressive lung disease characterized by airflow obstruction caused by chronic bronchitis or emphysema. It is the fourth leading cause of death in the US. Symptoms include cough, sputum production, and shortness of breath. Management involves smoking cessation, bronchodilators, corticosteroids, oxygen therapy, and lifestyle changes. Nurses play a key role in assessing patients, educating on self-management, and providing interventions to improve breathing and nutrition.
This document provides information on bronchial asthma, including:
- Asthma is a chronic inflammatory airway disease characterized by wheezing, breathlessness, and coughing.
- It affects over 350 million people globally and causes nearly 400,000 deaths per year, most in developing countries.
- Long-term treatment involves inhaled corticosteroids to reduce inflammation. Other treatments include oral corticosteroids, leukotriene modifiers, and long-acting beta-2 agonists.
- Triggers include infections, allergens, exercise, air pollution, weather changes, drugs, stress, and smoking. Proper management is needed to prevent complications and control symptoms.
This document discusses non-invasive positive pressure ventilation (NIPPV). It defines NIPPV as ventilation without an invasive airway and notes its increasing use for acute respiratory failure. The document covers the history of NIPPV, indications, goals, advantages, patient selection criteria, initiation procedures, modes (including CPAP, BiPAP, volume vs pressure), and settings. NIPPV can effectively treat various conditions like COPD, heart failure, and respiratory infections while avoiding intubation. Careful patient selection and monitoring are important for successful NIPPV.
This document discusses various chest and lower respiratory tract disorders including atelectasis, respiratory infections like pneumonia, diagnostic tests, medical treatments, and nursing care. Specific topics covered include prevention and treatment of atelectasis, types of pneumonia, nursing assessments and interventions for patients with pneumonia, diagnostic testing for pneumonia, medical management of pneumonia, respiratory infections like bronchitis, diagnostic testing and medical treatment of pneumonia, nursing care for patients with lung cancer, and chest trauma conditions.
This document provides guidance on ventilatory management of COVID-19 patients. It discusses preparing ICU units, criteria for ICU admission, general measures including oxygen supplementation and ventilation strategies. It covers the use of HFNO, NIV, intubation and airway management precautions. Ventilation strategies for ARDS like lung protective ventilation with lower tidal volumes are recommended. Other strategies like prone positioning, higher PEEP and recruitment maneuvers are discussed. ECMO is considered for refractory hypoxemia. Weaning, extubation and complications are also addressed.
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHEDevawrat Buche
COPD is a common preventable disease characterized by persistent airflow limitation associated with chronic inflammation in the airways and lungs due to noxious particles. The severity of COPD is assessed using symptoms, spirometry results, exacerbation risk, and comorbidities. Treatment involves smoking cessation, pharmacotherapy including bronchodilators and inhaled corticosteroids, rehabilitation, vaccination, and management of exacerbations with oxygen therapy, bronchodilators, corticosteroids, and antibiotics.
An overview of adult respiratory distress syndrome with a focus on the updates in ventilatory management of this important syndrome in the intensive care
These slides represent how to manage patients on a mechanical ventilator? Easy understanding of using ventilators. indication of mechanical ventilator use. How to wean a patient from a mechanical ventilator? How to fine-tune the ventilator settings?
This document summarizes a study comparing non-invasive positive pressure ventilation (NIPPV) to high flow oxygen therapy in immunocompromised patients with acute respiratory failure. The study found that early use of NIPPV as compared to oxygen therapy alone did not reduce 28-day mortality or intubation rates. There were also no differences in ICU or hospital length of stay. While NIPPV did not provide benefits, the lower than expected mortality with oxygen therapy alone limited the study's ability to detect differences between the groups.
This document discusses a case of a 45-year-old male presenting with toe pain secondary to gout who had an IV placed with subsequent air embolism due to failure to flush the IV tubing. It prompts for the diagnosis and treatment. Air embolism would be the diagnosis, and treatment would involve placing the patient in left lateral decubitus position and administering 100% oxygen via non-rebreather mask to reduce the size of the air bubbles and support oxygenation. The document goes on to discuss various topics relating to hyperbaric oxygen therapy including its physics, physiology, indications, disadvantages, evidence for use in emergency medicine, and reimbursement issues.
The document discusses chronic obstructive pulmonary disease (COPD) and its diagnosis and assessment. It provides guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for diagnosing and assessing COPD severity. Key points include that COPD is diagnosed based on symptoms and post-bronchodilator spirometry. Severity is assessed based on airflow limitation using spirometry grades (GOLD 1-4), exacerbation history, and symptoms using scales like mMRC and CAT. A combined assessment places patients into one of four categories (A-D) to guide management.
This document presents 6 case studies of patients presenting with dyspnoea or shortness of breath. Case 1 describes a 72-year-old woman admitted to the hospital with fever and progressive shortness of breath with a history of rheumatoid arthritis. Case 2 involves a 45-year-old heavy smoker with increasing dyspnea, cough, and finger clubbing. Case 3 is about a 76-year-old man with exertional dyspnea and multiple conditions including myasthenia gravis. Case 4 presents a 48-year-old male with fever, cough, weight loss, and right-sided chest pain and shortness of breath. Case 5 describes a 66-year-old woman with increasing shortness
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with high costs, morbidity, and mortality. They result in enormous healthcare expenditures and lost productivity. AECOPD episodes are also linked to accelerated long-term loss of lung function in continuous smokers. While symptoms may recover within a week, full recovery of health-related quality of life can take months. Noninvasive mechanical ventilation should be tried for patients with respiratory acidosis or increased work of breathing from AECOPD as it reduces intubation rates and improves health outcomes. Preventing and properly managing AECOPD is important for reducing its impacts.
Noninvasive ventilation may provide benefits as a weaning strategy compared to invasive weaning from mechanical ventilation. A systematic review and meta-analysis of randomized controlled trials found that noninvasive weaning significantly reduced mortality, rates of weaning failure and ventilator-associated pneumonia. It also decreased length of stay in the ICU and hospital as well as total duration of mechanical ventilation compared to invasive weaning. Subgroup analysis showed greater reduction in mortality for patients with COPD using noninvasive weaning.
1) ARDS is a common and serious condition in the ICU characterized by diffuse lung inflammation and damage to the lungs' ability to oxygenate blood. It can develop due to direct or indirect injury to the lungs from a variety of causes like pneumonia, sepsis, trauma, etc.
2) Mechanical ventilation can further damage injured lungs if not performed carefully. A lung protective strategy using low tidal volumes has been shown to significantly reduce mortality in ARDS patients.
3) Treatment involves identifying and treating the underlying cause, conservative fluid management, nutritional support, and lung protective ventilation with low tidal volumes and adequate PEEP to prevent lung collapse without overdistension.
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by rapid onset of severe breathing difficulties, low oxygen levels in the blood, and diffuse lung inflammation and fluid buildup leading to respiratory failure. It has two phases - an initial exudative phase where lung inflammation causes fluid buildup in the lungs, and a later proliferative phase where the lungs try to heal but can develop pulmonary fibrosis. Treatment focuses on supportive care, minimizing additional lung injury from mechanical ventilation, maintaining low fluid levels to prevent further pulmonary edema, and managing the underlying cause of the ARDS when possible. The mainstay of ventilation treatment is using low tidal volumes and adequate positive end-expiratory pressure to safely recruit and maintain open lung volumes without over
Dr. Nannika Pradhan presented on pulmonary hypertension (PH). The key points discussed include:
1. PH is defined as a mean pulmonary arterial pressure ≥25 mmHg at rest as assessed by right heart catheterization.
2. PH is classified clinically into 5 groups based on etiology.
3. Clinical features include dyspnea, chest pain, syncope, signs of right heart failure. Diagnosis involves echocardiogram, CT scan, ventilation-perfusion scan and right heart catheterization.
4. Treatment depends on disease severity and involves diuretics, oxygen supplementation, calcium channel blockers, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostano
This document provides information on Acute Respiratory Distress Syndrome (ARDS), including its history, definitions, pathophysiology, management, and related concepts like ventilator-induced lung injury. Some key points:
- ARDS was first described in 1967 and its definition has evolved, with the most widely used being the Berlin Definition from 2012.
- It is characterized by diffuse pulmonary edema and inflammation due to direct lung injury or indirect causes like sepsis.
- Management focuses on treating the underlying cause, protective lung ventilation with low tidal volumes, permissive hypercapnia, prone positioning, and recruitment maneuvers.
- Adjunctive techniques aim to prevent ventilator-induced lung injury from
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening lung condition caused by injury to the lungs. It can develop rapidly and cause inflammation and fluid buildup in the lungs. The key points are:
- ARDS was first described in 1967 and definitions have evolved over time to improve diagnosis. The Berlin Definition from 2012 is currently used.
- Common causes include pneumonia, aspiration, trauma, sepsis, and multiple transfusions. The condition progresses through exudative, proliferative, and fibrotic phases as the lungs attempt to heal.
- Management focuses on treating the underlying cause, protective lung ventilation with low tidal volumes, permissive hypercapnia, prone positioning, and fluid restriction
This document provides information on Acute Respiratory Distress Syndrome (ARDS), including its history, definitions, pathophysiology, management, and related concepts like ventilator-induced lung injury. Some key points:
- ARDS was first described in 1967 and its definition has evolved over time, with the current Berlin Definition from 2012 focusing on onset, severity based on oxygenation, and ruling out cardiogenic causes.
- Pathophysiology involves inflammation, increased permeability, and damage to the alveolar-capillary membrane leading to edema in three phases.
- Management focuses on treating the underlying cause and using a lung protective ventilation strategy with low tidal volumes, along with fluid restriction, permissive hypercap
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function.
This document provides an overview of acute respiratory distress syndrome (ARDS) including its definition, pathophysiology, clinical presentation, diagnosis, and management. Some key points:
- ARDS is characterized by acute hypoxemic respiratory failure due to widespread inflammation and fluid buildup in the lungs.
- Treatment involves supportive care with mechanical ventilation using low tidal volumes, maintaining adequate oxygen levels, treating the underlying cause, and considering rescue therapies for severe cases like prone positioning or extracorporeal membrane oxygenation.
- Mortality remains high at around 26-58% depending on severity, with the most common causes of death being complications of the initial insult or secondary infections like pneumonia. Ongoing research focuses on
High Flow Nasal Cannula - Grand Rounds 2018Jason Block
This document discusses the benefits and optimal use of high flow nasal cannula (HFNC) in the emergency department. It finds that HFNC is comfortable for patients, improves oxygenation, and decreases respiratory rate. It can be used effectively in both the ED and ICU to treat hypoxemic respiratory failure without hypercapnia. HFNC may reduce intubation and mortality compared to conventional oxygen therapy. It also maintains oxygenation during intubation and is preferable to other devices for preoxygenation. However, HFNC should be used cautiously for cardiogenic pulmonary edema and COPD given limited evidence.
1) Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition caused by injury to the lungs. It can result from direct lung injury, such as pneumonia, or indirect injury, like sepsis.
2) ARDS progresses through exudative and proliferative phases characterized by fluid accumulation and scarring in the lungs. This impairs gas exchange and causes respiratory failure.
3) Mechanical ventilation is used to treat respiratory failure but can further damage the lungs if not done carefully. The ARDSNet trial showed using low tidal volumes of 6 ml/kg improved survival compared to larger volumes.
This document provides an overview of acute respiratory distress syndrome (ARDS), including:
1) The updated Berlin definition of ARDS which requires a minimum PEEP of 5 cm H2O and specifies diagnostic criteria based on oxygenation levels.
2) The pathophysiology of ARDS involves an initial exudative phase followed by a proliferative phase and sometimes a fibrotic phase.
3) Management focuses on supportive ventilation with low tidal volumes and identification and treatment of precipitating factors, with corticosteroids and prone positioning helping in some cases. Refractory hypoxemia may be addressed through approaches like HFOV, IRV, APRV, inhaled nitric oxide, or ECMO.
The document discusses chronic obstructive pulmonary disease (COPD). It defines COPD as a progressive lung disease characterized by airflow obstruction caused by chronic bronchitis or emphysema. The document provides statistics on the prevalence and mortality of COPD worldwide and in India. It identifies the major risk factors, clinical manifestations, diagnostic evaluations, management including medications, oxygen therapy, surgery, and rehabilitation. It also discusses nursing care for patients with COPD.
This document discusses diffuse parenchymal lung diseases (DPLD), also known as interstitial lung diseases. It describes the different categories and subtypes of DPLD, including idiopathic interstitial pneumonias (IIP) such as idiopathic pulmonary fibrosis (IPF). IPF is the most important subtype of IIP, with a poor prognosis. The document outlines approaches to diagnosing and treating IPF.
1. The document discusses acute respiratory distress syndrome (ARDS), describing its pathophysiology, causes, diagnosis, treatment and prognosis.
2. ARDS is characterized by hypoxemia, reduced lung compliance and diffuse pulmonary infiltrates leading to respiratory failure. Common causes include sepsis, pneumonia and trauma.
3. Treatment involves treating the underlying cause, supportive care including mechanical ventilation with low tidal volumes, and managing fluid levels and oxygenation. Prognosis depends on severity of illness, with reported mortality ranging from 41-65%.
Acute respiratory Distress Syndrome - Medical and Nursing managementVarunMahajani
ARDS is an acute diffuse, inflammatory lung injury leading to pulmonary vascular permeability, increased lung weight, loss of aerated lung tissue with hypoxia, bilateral radiological opacities associated with increased venous admixture, increased physiological dead space, and decreased lung compliance.
this presentation provides in depth view of management of patient with ARDS
A 47-year-old obese male suffered a cardiac arrest at home and paramedics were called. Paramedics performed CPR, secured the patient's airway with an i-gel, administered epinephrine and amiodarone, and defibrillated multiple times. Extraction of the patient was difficult due to his size and the home's layout, interrupting chest compressions. The patient remained in asystole and died in the hospital. While guidelines were generally followed, opportunities were identified to improve outcomes through different drug protocols, better airway devices, and mechanical CPR devices to maintain compressions during difficult extractions.
This document provides an overview of acute respiratory distress syndrome (ARDS). It begins by defining ARDS as a sudden respiratory failure characterized by hypoxemia and diffuse lung infiltrates. Risk factors include age over 65, smoking history, sepsis, trauma and pneumonia. The pathophysiology involves three phases: exudative, proliferative and fibrotic. Management requires supportive care in an ICU including mechanical ventilation, positioning, fluids and antibiotics. The nursing priorities are to improve breathing and tissue perfusion while preventing complications like infection and skin breakdown.
This document provides an overview of acute respiratory distress syndrome (ARDS). It discusses the history and definitions of ARDS, causes, natural history involving three phases, clinical presentation, diagnosis, and management approaches including ventilator support, fluids, steroids, and other failed therapies. The goals of treatment are supporting cardio-pulmonary function and targeting the underlying lung injury. ARDS carries high mortality risks, especially when it arises from direct lung injury or in patients with preexisting organ dysfunction.
chronic obstructive pulmonary disease and its management
chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
COPD typically has a clear cause and a clear path of prevention, and there are ways to slow the progression of the disease.
This document provides guidelines for non-invasive positive pressure ventilation (NIPPV) in patients experiencing acute respiratory failure. It lists indications and contraindications for NIPPV, and protocols for its use, including settings for inspiratory and expiratory pressures. The document also describes the ventilator modes and parameters that should be set, including pressures, rates, and alarms. It notes that since SARS, there is hesitation to use NIPPV for community-acquired pneumonias due to infection risk.
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by rapid onset of bilateral pulmonary infiltrates and hypoxemia leading to respiratory failure. It is caused by acute diffuse inflammatory lung injury from a direct or indirect pulmonary insult. Diagnosis requires excluding left heart failure and evaluating for underlying causes. Pathologically, it involves diffuse alveolar damage and pulmonary edema. Treatment focuses on supportive care including mechanical ventilation, fluid management, and treatment of underlying conditions. While mortality has decreased in recent decades, ARDS still carries a significant risk of death.
4. • ARDS 1st known after the 1st world war as adult respiratory distress syndrome
•In 1994 the term acute respiratory distress syndrome is used instead of adult respiratory
distress syndrome by the American European consensus conference ( AECC) as it occurs in
both adult and children
HISTORICAL BACK GROUND
5. DEFINITION
• A life threatening acute persistent diffuse lung inflammation with increase in vascular permeability Ch by
1. Acute onset of tachypnea and tachycardia
2. Refractory hypoxemia
3. Diffuse bilateral alveolar infiltrate in CXR
4. P/F ratio < 300
5. Pathologically DAD
6. Exclusion of cardiac failure or fluid overload
( ECHO )
According to Berlin definition of ARDS 2012
6. • Mild P/F ratio 200-300
• Moderate P/F ratio 100-200
• Sever P/F ratio < 100
CLASSIFICATIONS
According to Berlin definition of ARDS 2012
7.
8. • Direct lung injury
• Indirect lung injury
AETIOLOGY
Paul L. Marino, 2014. the ICU book, 4th edition
9. • Pneumonia
• Aspiration of gastric contents
• Toxic inhalation
• Fat embolism
• Amniotic fluid embolism
• Lung contusion
• Near drowning
• Drugs as paraquat
• Radiation
DIRECT LUNG INJURY
Paul L. Marino, 2014. the ICU book, 4th edition
10. • Sepsis
• Multiple trauma
• Multiple blood transfusion
• Acute pancreatitis
• DIC
• Sever burn
• Anaphylaxis
• Cardioplumonary bypass
• Toxic ingestion as aspirin
INDIRECT LUNG INJURY
Paul L. Marino, 2014. the ICU book, 4th edition
11. • Exudative phase
• Proliferative phase
• Fibrotic phase
PATHOPHYSIOLOGY
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
12. • 1st 7 days
• Accumulation of fluid rich in ptn and inflammatory cells ( neutrophils and cytokines) in the interstitium with
dilution of alveolar surfactant and collapse
• Pulmonary vascular injury and obliteration by microthrombi and fibronodular proliferation
DAD
EXUDATIVE PHASE
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
13. • Stage of recovery
• 2nd and 3rd Wks
• Organization of alveolar exudate and Increase in pneumocyte type II with Early collagen deposition
• Shifting from neutrophilic to lymphocytic infiltration
PROLIFERATIVE PHASE
Stiff lung or shocked lung
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
14. • Progressive vascular occlusion with PHTN
• Extensive fibrosis with distortion of acinar architecture and emphysematous like changes with
lung bullae
FIBROTIC PHASE
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
15. • Surfactant abn
• Alv. Collapse
• Gas exchange defects
• Altered lung mechanics
• Incr pulm. shunt
• Incr dead space ventilation
• Decr lung compliance
• incr WOB
• Pulmonary hemodynamics defect with PHTN
• Hypoxemia
COLLECTIVELY
16.
17. • Progressive dyspnea
• Non productive cough
• Tachypnea and tachycardia
• Cyanosis
• Incr WOB with using accessory Ms of Resp
• Agitation and restlessness
• Scattered insp. Crepitations
• Systemic hypertension
typically started within 12-48 hs of the evolving event but may be longer
CLINICAL PICTURE
Paul L. Marino, 2014. the ICU book, 4th edition
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
18. • Imaging
• Laboratory
• Others
INVESTIGATIONS
Paul L. Marino, 2014. the ICU book, 4th edition
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
19. • CXR) cannot reliably differentiate hydrostatic edema, i.e., cardiogenic edema,
from ALI and ARDS. )
IMAGING
ECHO
Chest CT
Chest US
20. • No specific lab for ARDS
• BAL
• BNP
• ABG (In addition to hypoxemia initially shows respiratory alkalosis from hyperventilation however in case of sepsis may shows metabolic acidosis with or without resp. compensation )
• ESR and CRP
• Cardiac enzymes (creatine phosphokinase and troponins) are useful for evaluating the
presence of myocardial infarction or cardiac ischemia ( troponins, have been reported to be elevated in patients
with sepsis or septic shock in the absence of coronary artery disease.)
• Liver and renal function tests
LAB0RATORY
Paul L. Marino, 2014. the ICU book, 4th edition
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
21. • the most reliable method for confirming or excluding diagnosis of ARDS
• neutrophils in normal subject less than 5% but in ARDS up to 80%
• ptn BAL rich in ptn suggest evidence of lung inflammation and in relation to serum ptn the
following criteria can be applied:
L/S ptn less than 0.5% suggest hydrostatic edema while if more than 0.7% suggest lung
inflammation
• The main reason for performing bronchoscopy in ARDS is to rule in or rule out acute
processes that may have specific therapies for example, acute eosinophilic
pneumonia ( more than20% eosinophils ), diffuse alveolar hemorrhage (red cells and
hemosedrin laden macrophage), acute HP or BOOP ( high lymphcytosis).
BAL
Paul L. Marino, 2014. the ICU book, 4th edition
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
22. • in patient with hypoxic respiratory failure and bilateral alveolar infiltrates BNP level less than
100 pg/ml favor diagnosis of ARDS rather than cardiogenic palm. Edema while BNP greater
than 500 pg/ml indicates that CHF is likely .
BNP
Paul L. Marino, 2014. the ICU book, 4th edition
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
24. • No specific ttt ?
• principles
1- ttt of the underlying condition
2- management of respiratory failure ...........ttt of hypoxia
3- supportive care … fluid management.... inotropes...anti co agulant....VAP bundle ... nutritional care
4- other novel therapies surfactant .. anti oxidants(N acetyl cistein).... anti inflammatory( steroids,
statins and macrolides) inhaled BD (No and prostacycline) granulocyte monocyte +++ factor and ECMO
6_ future therapies ……..stem cell therapy.....APRV
PRINCIPLES OF MANAGMENT
25. • Decr O2 consumption
Common causes incr O2 consumption fever, pain, anxiety and use of resp.Ms
• Incr O2 delivery ……….MV?
TTT OF HYPOXIA
26. • People with acute respiratory distress syndrome (ARDS) are by definition severely hypoxemic,
and nearly all require invasive mechanical ventilation
• Yet mechanical ventilation itself can further injure damaged lungs (so-called ventilator-induced
lung injury) So low tidal volume ventilation is applied for ARDS
• Patient with mild ARDS may benefit from NIMV which may protect them from IMV
• NIV is proven to Increase oxygenation, Reduce dyspnea, Unload respiratory muscles.
• New modes for ARDS ……..APRV, ECMO, HFV and IRV
• Aim ?
Rajesh and Subhash, 2012. ICU protocols, respiratory system, basic of mechanical ventilation.
MV
27. • People with acute respiratory distress syndrome (ARDS) are by definition severely hypoxemic,
and nearly all require invasive mechanical ventilation
• Yet mechanical ventilation itself can further injure damaged lungs (so-called ventilator-induced
lung injury) So low tidal volume ventilation is applied for ARDS
• Patient with mild ARDS may benefit from NIMV which may protect them from IMV
• NIV is proven to Increase oxygenation, Reduce dyspnea, Unload respiratory muscles.
• New modes for ARDS ……..APRV, ECMO, HFOV and IRV
• Aim ? Open lung and keep it open
recruitment of lung and prevent de-recruitment
Airway pressure release ventilation
MV
28.
29. • Low TV
• Plateau less than 30 cm H2O
• Permissive hypercapnia
• Optimal PEEP
• Use recruitment manuvers
• Patient sedation to improve synchrony with ventilator and NMB frequently needed
PRINCIPLES OF LTVMV
Paul L. Marino, 2014. the ICU book, 4th edition
Richard S. Irwin and James M. Rippe, 2012. Intensive care medicine 7th edition
30.
31. • It is safe to allow pH to fall to at least 7.20.
• The actual pCO2 is of little importance.
• When pH falls below 7.20, many physicians choose to administer sodium bicarbonate
• Conditions in which permissive hypercapnia for ARDS could theoretically be harmful include:
1. Acute cerebrovascular disorders, e.g., stroke or seizures
2. Increased intracranial pressure from any cause
3. active coronary artery disease; arrhythmias
4. Hypovolemia or GI bleeding
5. Severe pulmonary hypertension
6. Right ventricular failure
7. Uncorrected severe metabolic acidosis
8. Sickle cell anemia
9. Pregnancy
PERMISSIVE HYPERCAPNIA
Paul L. Marino, 2014. the ICU book, 4th edition
32.
33. It can cause severe hemodynamic compromise and barotrauma So contraindicated when the patient
is hemodynamically unstable, or in the presence of intracranial hypertension, bronchospasm, lung
bullae, or an untreated pneumothorax
Clude Guerin et al, 2011. efficacy and safety of recruitment maneuvers in ARDS. Annals of intensive care 2011
34. Contraindications
Shock
Acute bleeding
Multiple trauma
Spinal instability
Pregnancy
Raised intracranial pressure
Abdominal surgery
PRONE POSITION
Prone positioning improves ventilation
Clude Guerin et al, 2011. efficacy and safety of recruitment maneuvers in ARDS. Annals of intensive care 2011
35. • 1st pain control by opioids for non neuropathic pain and non opioids to decrease the amount of
opioids
• Gabapentin or carbamazepine may added to opioids for neuropathic pain
• Non benzodiazepine sedatives are preferred (propofol and dexmedetomidine)
• Light sedation is preferred than deep sedation with daily sedation vacation after 48 hours
• Short term NMB for up to 48hs is safe and potentially benefit
• Aim??? Improve patient ventilator synchrony and elimination of muscle activity with
subsequent decr in oxygen consumption
Juliana Barr et al, clinical practice guidelines for management of pain, agitation and delirium in adullt patient in ICU. Critical care medicine 41(1) 2013
SEDATION
36. • conservative strategy of fluid management (target a CVP <4 mmHg or PAOP <8 mmHg)is
needed in patients with ARDS, as long as hypotension and organ hypoperfusion can be
avoided.
• The conservative strategy improved:
1. oxygenation index
2. lung injury score
3. ventilator-free days
4. ICU-free days.
SEPSIS??
FLUID MANAGEMENT
37. PROGNOSIS
• Mortality rate from 24% in age between 15-19 y to 60% in age 85y and more
• Exercise impairment and decrease quality of life related to both physical and
neuropsychological factors with Decr Dlco and abnormal 6 min walking test
38. • The clinical hallmark of ARDS is persistent hypoxemia
• The pathological hallmark of ARDS is DAD
• MOF is the most common cause of death
•While no pharmacological therapy have been shown to incr survival in ARDS LTV MV is life
saving
•Mortality rates have been decr but still high with survivors show many problems
• Defined as A life threatening acute persistent diffuse lung inflammation with increase in
vascular permeability OF Acute onset, Refractory hypoxemia, Diffuse bilateral alveolar
infiltrate in CXR, P/F ratio < 300 AND Exclusion of cardiac failure or fluid overload
• Caused by direct and indirect lung injury but sepsis is the most common cause
• Pathogenesis include 3 stages with the affection of alveolocapillary membrane is most
important
• Not a disease but A syndrome so no specific diagnostic tool or specific treatment
conclusion
39. • A syndrome started as …………
ending as ………..
summary
40. • A syndrome started as SIRS
ending as ………..
summary
41. • A syndrome started as SIRS
ending as MOF
summary